Live
FierceBiotechIterum initiates wind-down after failure to offload antibiotic with sluggish salesEndpoints NewsPharma goes on $25.5B, eight-day acquisition spreeEndpoints NewsAstraZeneca's next-gen hopeful for a rare bone condition fails pivotal trial10x Genomics BlogBioptimus launches massive patient data atlas to train its biology AI - R&D WorldIlluminaIllumina (ILMN) Valuation Check As Labcorp Partnership Expands In Precision Oncology - simplywall.stEndpoints NewsFDA identifies eight deaths tied to Amgen's TavneosWatersWaters Corporation Stock: Analytical Instruments Leader Positions for Growth Amid Strategic Acquisit - AD HOC NEWSAgilentComparison Of Different Methods To Isolate HMW DNA From Bacteria For Nanopore Sequencing - Bioprocess OnlineThermo FisherThermo Fisher's Glacios 3 Cryo-TEM targets the renovation barrier that has kept cryo-EM out of reach - R&D WorldLonza NewsLonza Strengthens Board With Nomination of Former Eli Lilly Executive Stephen Fry - TipRanks10x Genomics Blog10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout - 10x Genomics (NASDAQ:TXG) - BenzingaThermo FisherThermo Fisher Scientific Introduces Glacios 3 Cryo-TEM for Structural Biology Labs - Lab Manager
Endpoints News Mar 31, 2026

AstraZeneca's next-gen hopeful for a rare bone condition fails pivotal trial

AstraZeneca's next-gen hopeful for a rare bone condition fails pivotal trial

Original
Body unavailable. Use the original source.

Directory

59 All